EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia

Filip Milosavljević, Irene Brusini, Andrea Atanasov, Marina Manojlović, Marija Vučić, Zorana Oreščanin-Dušić, Jelena Brkljačić, Čedo Miljević, Aleksandra Nikolić-Kokić, Duško Blagojević, Chunliang Wang, Peter Damberg und 4 weitere

Neuropathology and Applied Neurobiology · 2023

DOI: 10.1111/nan.12867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2023. Verfasst von Filip Milosavljević und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: Cerebellar Diseases, Neurodegenerative Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hjärnfonden, Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

CYP2C19 transgenic mouse expresses the human CYP2C19 gene in the liver and developing brain, and it exhibits altered neurodevelopment associated with impairments in emotionality and locomotion. Because the validation of new animal models is essential for the understanding of the aetiology and pathophysiology of movement disorders, the objective was to characterise motoric phenotype in CYP2C19 transgenic mice and to investigate its validity as a new animal model of ataxia.

Methods

The rotarod, paw‐print and beam‐walking tests were utilised to characterise the motoric phenotype. The volumes of 20 brain regions in CYP2C19 transgenic and wild‐type mice were quantified by 9.4T gadolinium‐enhanced post‐mortem structural neuroimaging. Antioxidative enzymatic activity was quantified biochemically. Dopaminergic alterations were characterised by chromatographic quantification of concentrations of dopamine and its metabolites and by subsequent immunohistochemical analyses. The beam‐walking test was repeated after the treatment with dopamine receptor antagonists ecopipam and raclopride.

Results

CYP2C19 transgenic mice exhibit abnormal, unilateral ataxia‐like gait, clasping reflex and 5.6‐fold more paw‐slips in the beam‐walking test; the motoric phenotype was more pronounced in youth. Transgenic mice exhibited a profound reduction of 12% in cerebellar volume and a moderate reduction of 4% in hippocampal volume; both regions exhibited an increased antioxidative enzyme activity. CYP2C19 mice were hyperdopaminergic; however, the motoric impairment was not ameliorated by dopamine receptor antagonists, and there was no alteration in the number of midbrain dopaminergic neurons in CYP2C19 mice.

Conclusions

Humanised CYP2C19 transgenic mice exhibit altered gait and functional motoric impairments; this phenotype is likely caused by an aberrant cerebellar development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebellar DiseasesNeurodegenerative DiseasesHumansMiceAnimalsAdolescentMice, TransgenicCytochrome P-450 CYP2C19AtaxiaCerebellumAtrophyDisease Models, Animal

Stichwörter der Autor:innen

animal modelscerebellar ataxiacerebellumcytochrome P-450 Cyp2c19movement disordersneuroimagingtransgenic mice

Substanzen

Cytochrome P-450 CYP2C19CYP2C19 protein, human

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
  • Department of Biomedical Engineering and Health Systems, KTH Royal Institute of Technology, Huddinge, Sweden.
  • Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Huddinge, Sweden.
  • Institute for Biological Research "Siniša Stanković" - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
  • Department of Psychiatry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Institute for Mental Health, Belgrade, Serbia.

Förderung

  • Hjärnfonden
  • Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Zitieren

APA

Milosavljević, F., Brusini, I., Atanasov, A., Manojlović, M., Vučić, M., Oreščanin-Dušić, Z., Brkljačić, J., Miljević, Č., Nikolić-Kokić, A., Blagojević, D., Wang, C., Damberg, P., Pešić, V., Tyndale, R. F., Ingelman-Sundberg, M., & Jukić, M. M. (2023). The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12867

Vancouver

Milosavljević F, Brusini I, Atanasov A, Manojlović M, Vučić M, Oreščanin-Dušić Z, et al. The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia. Neuropathology and Applied Neurobiology. 2023. doi:10.1111/nan.12867

BibTeX
@article{Milosavljevi2023,
  author = {Milosavljević, Filip and Brusini, Irene and Atanasov, Andrea and Manojlović, Marina and Vučić, Marija and Oreščanin-Dušić, Zorana and Brkljačić, Jelena and Miljević, Čedo and Nikolić-Kokić, Aleksandra and Blagojević, Duško and Wang, Chunliang and Damberg, Peter and Pešić, Vesna and Tyndale, Rachel F and Ingelman-Sundberg, Magnus and Jukić, Marin M},
  title = {The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2023},
  doi = {10.1111/nan.12867}
}
Kostenlos starten →